Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

General Medicine

Hematology/Oncology

Involvement of DPP9 in gene fusions in serous ovarian carcinoma

BMC Cancer | Sep 15, 2017 Hematology/Oncology

MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinicalâpathological features and outcome

Virchows Archiv | Sep 15, 2017 Hematology/Oncology

Coronary angiography with or without percutaneous coronary intervention in patients with hemophilia: Systematic review

Catheterization and Cardiovascular Interventions | Evidence based | Sep 15, 2017 Hematology/Oncology

Assessment of acute bowel function after radiotherapy for prostate cancer: Is it accurate enough?

Clinical and Translational Oncology | Sep 15, 2017 Hematology/Oncology

Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors

OncoTargets and Therapy | Sep 15, 2017 Hematology/Oncology

Results of short-term follow-up in BI-RADS 3 and 4a breast lesions with a histological diagnosis of fibroadenoma at percutaneous needle biopsy

Breast Care | Sep 15, 2017 Hematology/Oncology

Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): Final results from a randomised, double-blind, phase 3 study

The Lancet Haematology | Sep 15, 2017 Hematology/Oncology

Standard of care and direct medical costs of the treatment of chronic lymphocytic leukemia among the adult population in Ukraine, Russia, and Kazakhstan: data from the LEUKOSPECT study

Cancer Management and Research | Sep 15, 2017 Hematology/Oncology

A clinical comparison of short-term efficacy, survival and adverse reactions between raltitrexed/cisplatin-based and docetaxel/cisplatin-based concurrent chemoradiotherapy in the treatment of advanced esophageal squamous cell carcinoma

Translational Cancer Research | Sep 15, 2017 Hematology/Oncology

Durvalumab after chemoradiotherapy in stage III nonâsmall-cell lung cancer

New England Journal of Medicine | Sep 14, 2017 Hematology/Oncology

« Prev 1 … 214 215 216 217 218 … 261 Next »

Involvement of DPP9 in gene fusions in serous ovarian carcinoma

MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinicalâpathological features and outcome

Coronary angiography with or without percutaneous coronary intervention in patients with hemophilia: Systematic review

Assessment of acute bowel function after radiotherapy for prostate cancer: Is it accurate enough?

Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors

Results of short-term follow-up in BI-RADS 3 and 4a breast lesions with a histological diagnosis of fibroadenoma at percutaneous needle biopsy

Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): Final results from a randomised, double-blind, phase 3 study

Standard of care and direct medical costs of the treatment of chronic lymphocytic leukemia among the adult population in Ukraine, Russia, and Kazakhstan: data from the LEUKOSPECT study

A clinical comparison of short-term efficacy, survival and adverse reactions between raltitrexed/cisplatin-based and docetaxel/cisplatin-based concurrent chemoradiotherapy in the treatment of advanced esophageal squamous cell carcinoma

Durvalumab after chemoradiotherapy in stage III nonâsmall-cell lung cancer

New Treatment in Uveitis

Optimising Caesarean Section Practices

MIP: Snake Bite Management: Dr Surajit Giri

The evolving landscape of CDK4/6i therapy in metastatic Breast Cancer: Experts discuss key findings and future directions

Mount Sinai is first in the nation to perform deep brain stimulation implant as part of clinical trial for depression

Involvement of DPP9 in gene fusions in serous ovarian carcinoma

MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinicalâpathological features and outcome

Coronary angiography with or without percutaneous coronary intervention in patients with hemophilia: Systematic review

Assessment of acute bowel function after radiotherapy for prostate cancer: Is it accurate enough?

Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors

Results of short-term follow-up in BI-RADS 3 and 4a breast lesions with a histological diagnosis of fibroadenoma at percutaneous needle biopsy

Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): Final results from a randomised, double-blind, phase 3 study

Standard of care and direct medical costs of the treatment of chronic lymphocytic leukemia among the adult population in Ukraine, Russia, and Kazakhstan: data from the LEUKOSPECT study

A clinical comparison of short-term efficacy, survival and adverse reactions between raltitrexed/cisplatin-based and docetaxel/cisplatin-based concurrent chemoradiotherapy in the treatment of advanced esophageal squamous cell carcinoma

Durvalumab after chemoradiotherapy in stage III nonâsmall-cell lung cancer

New Treatment in Uveitis

Optimising Caesarean Section Practices

MIP: Snake Bite Management: Dr Surajit Giri

The evolving landscape of CDK4/6i therapy in metastatic Breast Cancer: Experts discuss key findings and future directions

Mount Sinai is first in the nation to perform deep brain stimulation implant as part of clinical trial for depression

Select Specialty

Select Topic

MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinicalâpathological features and outcome

Durvalumab after chemoradiotherapy in stage III nonâsmall-cell lung cancer